Our top pick for
Building a portfolio
IBEX Limited is a software-application business based in the US. IBEX shares (IBEX) are listed on the NASDAQ and all prices are listed in US Dollars. IBEX employs 22,976 staff and has a trailing 12-month revenue of around 0.00.
|52-week range||$9.27 - $25.00|
|50-day moving average||$21.76|
|200-day moving average||$19.38|
|Wall St. target price||$26.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.14|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing IBEX stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of IBEX's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
IBEX's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 157x. In other words, IBEX shares trade at around 157x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
IBEX's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $28.6 million.
The EBITDA is a measure of a IBEX's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$428 million|
|Operating margin TTM||4.69%|
|Gross profit TTM||$111.6 million|
|Return on assets TTM||8.75%|
|Return on equity TTM||0%|
|Market capitalisation||$411.2 million|
TTM: trailing 12 months
There are currently 49,174 IBEX shares held short by investors – that's known as IBEX's "short interest". This figure is 6.6% down from 52,666 last month.
There are a few different ways that this level of interest in shorting IBEX shares can be evaluated.
IBEX's "short interest ratio" (SIR) is the quantity of IBEX shares currently shorted divided by the average quantity of IBEX shares traded daily (recently around 24835.353535354). IBEX's SIR currently stands at 1.98. In other words for every 100,000 IBEX shares traded daily on the market, roughly 1980 shares are currently held short.
However IBEX's short interest can also be evaluated against the total number of IBEX shares, or, against the total number of tradable IBEX shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case IBEX's short interest could be expressed as 0% of the outstanding shares (for every 100,000 IBEX shares in existence, roughly 0 shares are currently held short) or 0.0088% of the tradable shares (for every 100,000 tradable IBEX shares, roughly 9 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against IBEX.
Find out more about how you can short IBEX stock.
We're not expecting IBEX to pay a dividend over the next 12 months.
IBEX Limited provides end-to-end technology-enabled customer lifecycle experience solutions in the United States and internationally. The company provides ibex Connect, a customer engagement solution comprises customer service, technical support, and other value-added outsourced back office services through voice, email, chat, SMS, social media and other communication applications; ibex Digital, a customer acquisition solution that offers search, social, and display advertising capabilities; and ibex CX, a customer experience solution, which provides a comprehensive suite of proprietary software tools to measure, monitor and manage its clients' customer experience. It also operates a range of multi-tenant and dedicated platforms; and offers ibex Wave X, CLX Test Kitchen, and The CLX Product Cloud, a flexible and modular toolset of integrated products. As of June 30, 2020, the company operated 25 customer engagement and three customer acquisition delivery centers. It serves telecommunications and cable, technology, retail, healthcare, financial services, and utilities markets. The company was founded in 2017 and is headquartered in Washington, District of Columbia. IBEX Limited operates as a subsidiary of Resource Group International Limited.
Everything we know about the Talaris Therapeutics IPO, plus information on how to buy in.
Everything we know about the Sagimet Biosciences IPO, plus information on how to buy in.
Everything we know about the Zenvia IPO, plus information on how to buy in.
Everything we know about the Grove IPO, plus information on how to buy in.
Everything we know about the Pasithea Therapeutics IPO, plus information on how to buy in.
Features, fees and complaints to consider before you apply for a T. Rowe Price account.
Steps to owning and managing ZTO, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZOM, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZI, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZKIN, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.